Role of Lipoprotein(a) in Cardiovascular Disease: A Review of Clinical Practice
Journal of Asian Pacific Society of Cardiology · 2022
DOI: 10.15420/japsc.2021.31 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Asian Pacific Society of Cardiology, 2022. Verfasst von Yoshiyasu Minami und 4 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The association between elevated lipoprotein(a) (Lp(a)) and an increased risk of cardiovascular disease has been demonstrated. Although the impact of Lp(a) plasma level on the onset of disease depends on the type of disease and the patient’s comorbidities, an Lp(a) plasma level >1.29 mmol/l (50 mg/dl) has been proposed as a practical cut-off. Approximately 10% of the general Asian population may have Lp(a) >1.29 mmol/l, as do 15–30% of the global population. An alternative cut-off for Asian populations may be 0.78 mmol/l (30 mg/dl). Measurements may have to be considered at least once in each adult’s lifetime, particularly for people with a family or personal history of premature atherosclerotic cardiovascular disease. Although plasma level is mostly consistent throughout life, some therapies, such as proprotein convertase subtilisin/kexin type 9 inhibitors and antisense oligonucleotides, may reduce the Lp(a) plasma level.
Zitieren
APA
Minami, Y., Kinoshita, D., Muramatsu, Y., Nagata, T., & Ako, J. (2022). Role of Lipoprotein(a) in Cardiovascular Disease: A Review of Clinical Practice. Journal of Asian Pacific Society of Cardiology. https://doi.org/10.15420/japsc.2021.31
Vancouver
Minami Y, Kinoshita D, Muramatsu Y, Nagata T, Ako J. Role of Lipoprotein(a) in Cardiovascular Disease: A Review of Clinical Practice. Journal of Asian Pacific Society of Cardiology. 2022. doi:10.15420/japsc.2021.31
BibTeX
@article{Minami2022,
author = {Minami, Yoshiyasu and Kinoshita, Daisuke and Muramatsu, Yusuke and Nagata, Takako and Ako, Junya},
title = {Role of Lipoprotein(a) in Cardiovascular Disease: A Review of Clinical Practice},
journal = {Journal of Asian Pacific Society of Cardiology},
year = {2022},
doi = {10.15420/japsc.2021.31}
}
EUVIMED